chr12-123694870-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_024809.5(TCTN2):​c.1128T>C​(p.Pro376Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.457 in 1,611,480 control chromosomes in the GnomAD database, including 177,967 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 24168 hom., cov: 32)
Exomes 𝑓: 0.45 ( 153799 hom. )

Consequence

TCTN2
NM_024809.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.320

Publications

29 publications found
Variant links:
Genes affected
TCTN2 (HGNC:25774): (tectonic family member 2) This gene encodes a type I membrane protein that belongs to the tectonic family. Studies in mice suggest that this protein may be involved in hedgehog signaling, and essential for ciliogenesis. Mutations in this gene are associated with Meckel syndrome type 8. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
TCTN2 Gene-Disease associations (from GenCC):
  • Joubert syndrome 24
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Meckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 12-123694870-T-C is Benign according to our data. Variant chr12-123694870-T-C is described in ClinVar as Benign. ClinVar VariationId is 126283.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.32 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.815 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TCTN2NM_024809.5 linkc.1128T>C p.Pro376Pro synonymous_variant Exon 10 of 18 ENST00000303372.7 NP_079085.2 Q96GX1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TCTN2ENST00000303372.7 linkc.1128T>C p.Pro376Pro synonymous_variant Exon 10 of 18 1 NM_024809.5 ENSP00000304941.5 Q96GX1-1

Frequencies

GnomAD3 genomes
AF:
0.530
AC:
80470
AN:
151964
Hom.:
24113
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.822
Gnomad AMI
AF:
0.552
Gnomad AMR
AF:
0.399
Gnomad ASJ
AF:
0.405
Gnomad EAS
AF:
0.150
Gnomad SAS
AF:
0.464
Gnomad FIN
AF:
0.347
Gnomad MID
AF:
0.519
Gnomad NFE
AF:
0.450
Gnomad OTH
AF:
0.492
GnomAD2 exomes
AF:
0.424
AC:
106367
AN:
251142
AF XY:
0.427
show subpopulations
Gnomad AFR exome
AF:
0.834
Gnomad AMR exome
AF:
0.277
Gnomad ASJ exome
AF:
0.400
Gnomad EAS exome
AF:
0.153
Gnomad FIN exome
AF:
0.360
Gnomad NFE exome
AF:
0.450
Gnomad OTH exome
AF:
0.430
GnomAD4 exome
AF:
0.449
AC:
655228
AN:
1459398
Hom.:
153799
Cov.:
34
AF XY:
0.450
AC XY:
326406
AN XY:
725976
show subpopulations
African (AFR)
AF:
0.841
AC:
28119
AN:
33426
American (AMR)
AF:
0.292
AC:
13029
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.396
AC:
10315
AN:
26068
East Asian (EAS)
AF:
0.121
AC:
4806
AN:
39656
South Asian (SAS)
AF:
0.492
AC:
42388
AN:
86218
European-Finnish (FIN)
AF:
0.356
AC:
18971
AN:
53306
Middle Eastern (MID)
AF:
0.469
AC:
2702
AN:
5756
European-Non Finnish (NFE)
AF:
0.457
AC:
507534
AN:
1110020
Other (OTH)
AF:
0.454
AC:
27364
AN:
60266
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
16949
33898
50848
67797
84746
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15164
30328
45492
60656
75820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.530
AC:
80579
AN:
152082
Hom.:
24168
Cov.:
32
AF XY:
0.521
AC XY:
38724
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.822
AC:
34127
AN:
41514
American (AMR)
AF:
0.399
AC:
6093
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.405
AC:
1406
AN:
3470
East Asian (EAS)
AF:
0.149
AC:
774
AN:
5184
South Asian (SAS)
AF:
0.463
AC:
2232
AN:
4822
European-Finnish (FIN)
AF:
0.347
AC:
3658
AN:
10546
Middle Eastern (MID)
AF:
0.517
AC:
152
AN:
294
European-Non Finnish (NFE)
AF:
0.450
AC:
30593
AN:
67966
Other (OTH)
AF:
0.495
AC:
1045
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1687
3373
5060
6746
8433
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
680
1360
2040
2720
3400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.472
Hom.:
35393
Bravo
AF:
0.541
Asia WGS
AF:
0.357
AC:
1245
AN:
3478
EpiCase
AF:
0.453
EpiControl
AF:
0.453

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Meckel syndrome, type 8 Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:3
Jan 08, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Joubert syndrome 24 Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Meckel-Gruber syndrome;C0431399:Joubert syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
5.6
DANN
Benign
0.55
PhyloP100
0.32
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7966867; hg19: chr12-124179417; COSMIC: COSV57631977; COSMIC: COSV57631977; API